Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
close this folder12. TUBERCULOSIS AND LEPROSY
close this folder12.1 Tuberculosis
View the document12.1.1 Control of Tuberculosis
View the document12.1.2 Case Management
Open this folder and view contents12.1.3 Treatment Categories
View the document12.1.4 New Cases Other Than Smear Positive (PT)
View the document12.1.5 Chronic Cases
Open this folder and view contents12.2 Leprosy
Open this folder and view contents12.3 Treatment of Leprosy
View the document12.4 Prevention of Disabilities and rehabilitation
Open this folder and view contents12.5 Signs and Treatment of Severe Reversal Reaction (RR)
View the document12.6 Responsibilities
View the document12.7 How to Look After Ulcers
View the document12.8 Surveillance of Patients After Release from MDT
View the document12.9 Referral Criteria of Leprosy Patients
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 
12.1.2 Case Management

Diagnosis

Sputum

Each patient should have direct smear microscopy (DSM) on 3 sputum specimens for diagnosis. DSM should be repeated at the end of the intensive phase to confirm sputum conversion.

Sputum of TB patients MUST be sent or taken to the TB Reference Laboratory when:

• sputum conversion to negative has not taken place
• there is concern that the patient has developed drug resistance
• culture and sensitivities are required


Chest X-rays

This have to be done upon:

• admission for diagnosis
• completion of outpatient treatment


NOTE To reduce the rate of exposure of the patients, any other films can be taken only where specifically indicated. An X-ray at the end of the intensive phase is not likely to provide any additional benefit.

Tuberculin Testing

Use Mantoux test only

Tuberculin, dried (PPD) 1:1000 intradermal 0.1 ml 5 TU.

Examine after 48-72 hours.

Positive Mantoux Test

Adults

Indulation > 10 mm

Children

Indulation > 6 mm

These results may indicate:

• active infection (especially when strongly positive)
• previous infection or
• previous BCG


NOTE Absence of a response does not exclude TB because individuals with HIV may not have sufficient immunity for a positive Mantoux Test despite active TB

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French